Please assess the completion status of the following clinical trial:

Trial Title: LNG-IUS at 2 Weeks Postpartum

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Desiring a LNG-IUS~2. Postpartum, ages 18-45 who deliver at a gestational age \> 32 weeks, delivery can be via cesarean or vaginal delivery~3. Following a viable, singleton pregnancy~4. Willing to return to UNC for their LNG-IUS insertion and study follow-up~5. Who plan to stay in the UNC area for 6 months and willing to return to UNC for 3 visits~6. Fluent in English or Spanish~7. At risk of repeat pregnancy (i.e. excluding those who had tubal sterilization)~Exclusion Criteria:~1. No genital bleeding of unknown etiology~2. No personal history of known or suspected breast carcinoma~3. No 4th degree vaginal laceration at time of delivery~4. No documented uterine rupture during delivery~5. No active liver disease (resolved pre-eclampsia may enroll)~6. No evidence of vaginal, cervical or uterine infection at time of LNG-IUS insertion~7. No history of postpartum endometritis treated with antibiotics or a postpartum readmission for a dilation and curettage~8. No pre-existing contraindication to a LNG-IUS as determined by the CDC's Medical Eligibility Criteria (MEC) category 3 or 4~9. Not currently incarcerated~10. No known congenital or acquired uterine anomaly, including fibroids that distort the uterine cavity~11. No suspected hypersensitivity or contraindication to the LNG-IUS~12. With any other condition or circumstance that the PI determines could cause an adverse event or interfere with completing the study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- LNG-IUS placed at 2 weeks postpartum (Type: EXPERIMENTAL): Enrolled women will have the LNG-IUS placed at two-weeks (14-20 days) postpartum

Based on this trial design, predict the completion outcome and termination type (if applicable).